News

7.2026 Our latest work, published in the JCI, uncovers how nutrient sensing drives chemotherapy resistance. We show that SLC15A3-mediated dipeptide metabolism activates mTORC1 to promote lymphoma survival under antimetabolite therapy, revealing a new metabolic vulnerability. This study reflects our long-standing interest in how nutrient sensing regulates disease and lays the foundation for our new research program at Stony Brook exploring metabolism, translation, and aging.

Haojun will launch her independent research group in the Department of Pharmacological Sciences, Stony Brook University in March 2026.